6 billion cardiovascular drugs 34 pharmaceutical companies have been rated! Can Pfizer's half-walled mountains hold on?

Pharmaceutical Network August 10, August 7, CDE official website shows that Xi'an Blue New Tong Pharmaceuticals benzene sulfonate chloride flat tablet 4 types of imitation listing application seisiscope was accepted.
-meter net data show that in China's public medical institutions terminal ammonia chlorpyrifos tablets in the past two years, the sales scale of more than 6 billion yuan. Pfizer topped the
TOP20 brand and China Resources Co. Pharmaceuticals was second.
so far, a total of 34 pharmaceutical companies have passed consistency evaluation, and more than 90% have been approved for supplementary applications.
data show that benzodiazepine seinflat tablets are mainly used for the treatment of hypertension, coronary heart disease, the original research manufacturers for Pfizer Pharmaceuticals, the name of the product live joy.
2019 China's public medical institutions terminal ammonia chlorite tablet TOP20 brand pattern Minet net data show that in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal ammonia chlorite tablets sales in the past two years have exceeded 6 billion yuan. Pfizer topped the
TOP20 brand and China Resources Co. Pharmaceuticals was second.
note that Pfizer's market share has declined in recent years, from 63.02 percent in 2015 to 57.96 percent in 2019, as domestic drug companies have grown.
so far, a total of 34 pharmaceutical companies have passed consistency evaluation, and more than 90% have been approved for supplementary applications. In addition,
, the consistency evaluation supplementary application being reviewed by the phenyl sulfonate chlorate tablets has 6 enterprises, such as Jiangsu Kangyuan Pharmaceutical, Shenyang Sanyuan Pharmaceutical, involving 7 acceptance numbers;
Source: CDE Official Website, Mnet.com Database.